drugset
drugset / Trial / NCT04177433

The Use of Intra-articular Corticosteroid Injection to Treat Osteoarthritis of the Carpometacarpal Joint

NCT04177433 ↗

Phase 4 Completed 61 enrolled University of Alberta
RandomizedParallel-groupTriple-blindTreatment

Summary

This randomized clinical trial (RCT) will evaluate 6-month outcomes following intra-articular injections for arthritis of the thumb carpometacarpal (CMC) joint by comparing corticosteroid plus local anesthetic versus saline (placebo) plus local anesthetic.

Timeline

Start
2020-12-02
Primary completion
2025-09-29
Completion
2025-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Methylprednisolone Other / unclassified 40 mg Other

Indications

osteoarthritis, hand